Skip to main content
OpenTrials

Clinical trial condition

Recurrent Breast Carcinoma

Explore clinical trials studying Recurrent Breast Carcinoma. Study availability and eligibility vary by location and protocol.

71 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Breast Carcinoma trial results

Active, Not Recruiting

Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer

NCT01351909

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Unresectable Breast Carcinoma, +9 more
Locations
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
  • Montefiore Medical Center-Weiler Hospital The Bronx, New York, United States
View Trial Details
Active, Not Recruiting

Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

NCT02311933

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +9 more
Locations
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 560 locations
View Trial Details
Active, Not Recruiting

Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy

NCT03281902

Conditions
Advanced Breast Carcinoma, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer

NCT03737695

Conditions
Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer

NCT03939897

Conditions
Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • UC Irvine Health Cancer Center-Newport Costa Mesa, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer

NCT03941730

Conditions
Advanced Triple-Negative Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +9 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View Trial Details
Active, Not Recruiting

Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer

NCT03971409

Conditions
Breast Diseases, Breast Neoplasms, Invasive Breast Carcinoma, +13 more
Locations
  • O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of California, San Francisco San Francisco, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • University of Chicago Medicine Comprehensive Cancer Center Evergreen Park, Illinois, United States
View Trial Details

Related conditions